Recombinant multi-species MALT1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MALT1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a caspase-like protease that plays a role in BCL10-induced activation of NF-kappaB. The protein is a component of the CARMA1-BCL10-MALT1 (CBM) signalosome that triggers NF-kappaB signaling and lymphoctye activation following antigen-receptor stimulation. Mutations in this gene result in immunodeficiency 12 (IMD12). This gene has been found to be recurrently rearranged in chromosomal translocations with other genes in mucosa-associated lymphoid tissue lymphomas, including a t(11;18)(q21;q21) translocation with the baculoviral IAP repeat-containing protein 3 (also known as apoptosis inhibitor 2) locus [BIRC3(API2)-MALT1], and a t(14;18)(q32;q21) translocation with the immunoglobulin heavy chain locus (IGH-MALT1). Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, May 2018]
The Alternative Names of target: A630046N12,D430033E09Rik,IMD12,MALT lymphoma-associated translocation,MALT1,MLT,MLT1,Malt1,Mucosa-associated lymphoid tissue lymphoma translocation protein 1,PCASP1,Paracaspase,Pcasp1

Target products collectionGo to MALT1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T92678-Ag-1/ GM-Tg-hg-T92678-Ag-2 Human MALT1 protein Human
GM-Tg-rg-T92678-Ag-1/ GM-Tg-rg-T92678-Ag-2 Rat MALT1 protein Rat
GM-Tg-mg-T92678-Ag-1/ GM-Tg-mg-T92678-Ag-2 Mouse MALT1 protein Mouse
GM-Tg-cynog-T92678-Ag-1/ GM-Tg-cynog-T92678-Ag-2 Cynomolgus/Rhesus macaque MALT1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T92678-Ag-1/ GM-Tg-felg-T92678-Ag-2 Feline MALT1 protein Feline
GM-Tg-cang-T92678-Ag-1/ GM-Tg-cang-T92678-Ag-2 Canine MALT1 protein Canine
GM-Tg-bovg-T92678-Ag-1/ GM-Tg-bovg-T92678-Ag-2 Bovine MALT1 protein Bovine
GM-Tg-equg-T92678-Ag-1/ GM-Tg-equg-T92678-Ag-2 Equine MALT1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T92678-Ag-1/ GM-Tg-hg-T92678-Ag-2; GM-Tg-rg-T92678-Ag-1/ GM-Tg-rg-T92678-Ag-2;
GM-Tg-mg-T92678-Ag-1/ GM-Tg-mg-T92678-Ag-2; GM-Tg-cynog-T92678-Ag-1/ GM-Tg-cynog-T92678-Ag-2;
GM-Tg-felg-T92678-Ag-1/ GM-Tg-felg-T92678-Ag-2; GM-Tg-cang-T92678-Ag-1/ GM-Tg-cang-T92678-Ag-2;
GM-Tg-bovg-T92678-Ag-1/ GM-Tg-bovg-T92678-Ag-2; GM-Tg-equg-T92678-Ag-1/ GM-Tg-equg-T92678-Ag-2
Products Name MALT1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name MALT1
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MALT1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.